Augmented medial rectus recession versus botulinum toxin therapy for acute acquired comitant esotropia: analysis of outcomes and recurrence predictors
Sign Up to like & getrecommendations! Published in 2025 at "British Journal of Ophthalmology"
DOI: 10.1136/bjo-2025-328201
Abstract: Objective To compare the motor and sensory outcomes and quality of life (QOL) of augmented medial rectus recession (aMRc) and botulinum toxin A (BTXA) therapy in acute acquired comitant esotropia (AACE) treatment and to investigate… read more here.
Keywords: treatment; medial rectus; augmented medial; group ... See more keywords
Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
Sign Up to like & getrecommendations! Published in 2019 at "International Neurourology Journal"
DOI: 10.5213/inj.1938030.015
Abstract: Purpose Intradetrusor onabotulinum toxin A (BTXA) and sacral neuromodulation (SNM) are effective third-line therapies for overactive bladder (OAB). We aimed to measure the outcomes of BTXA for treatment of OAB refractory to initial SNM and… read more here.
Keywords: intradetrusor onabotulinum; snm; treatment; btxa ... See more keywords